GeoVax Labs, Inc.
GOVX
$0.9145
-$0.0955-9.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.95M | 3.09M | 300.70K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.95M | 3.09M | 300.70K | -- | -- |
| Cost of Revenue | 23.71M | 22.34M | 21.88M | 22.33M | 20.72M |
| Gross Profit | -19.76M | -19.25M | -21.58M | -22.33M | -20.72M |
| SG&A Expenses | 5.39M | 5.24M | 5.66M | 6.03M | 6.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.10M | 27.58M | 27.54M | 28.36M | 26.74M |
| Operating Income | -25.14M | -24.49M | -27.24M | -28.36M | -26.74M |
| Income Before Tax | -24.99M | -24.32M | -26.92M | -27.78M | -25.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.99 | -24.32 | -26.92 | -27.78 | -25.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.99M | -24.32M | -26.92M | -27.78M | -25.97M |
| EBIT | -25.14M | -24.49M | -27.24M | -28.36M | -26.74M |
| EBITDA | -25.05M | -24.40M | -27.16M | -28.28M | -26.67M |
| EPS Basic | -6.23 | -9.21 | -13.05 | -14.85 | -14.68 |
| Normalized Basic EPS | -3.89 | -5.75 | -8.16 | -9.28 | -9.17 |
| EPS Diluted | -6.23 | -9.21 | -13.05 | -14.85 | -14.68 |
| Normalized Diluted EPS | -3.89 | -5.75 | -8.16 | -9.28 | -9.17 |
| Average Basic Shares Outstanding | 20.96M | 13.29M | 8.66M | 7.68M | 7.07M |
| Average Diluted Shares Outstanding | 20.96M | 13.29M | 8.66M | 7.68M | 7.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |